$FPRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIVE PRIME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in FIVE PRIME THERAPEUTICS, INC.. Get notifications about new insider transactions in FIVE PRIME THERAPEUTICS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | President & CEO | Grant | A | 0.00 | 13,845 | 0 | 191,367 | 177.5 K to 191.4 K (+7.80 %) |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | SVP, Research | Option Exercise | A | 18.69 | 35,000 | 654,150 | 35,000 | |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | SVP, Research | Grant | A | 0.00 | 6,000 | 0 | 21,000 | 15 K to 21 K (+40.00 %) |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Executive Chairman | Option Exercise | A | 18.69 | 30,000 | 560,700 | 30,000 | |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Executive Chairman | Grant | A | 0.00 | 5,000 | 0 | 381,237 | 376.2 K to 381.2 K (+1.33 %) |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | A | 18.69 | 18,000 | 336,420 | 18,000 | |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Grant | A | 0.00 | 3,000 | 0 | 16,314 | 13.3 K to 16.3 K (+22.53 %) |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Option Exercise | A | 18.69 | 20,000 | 373,800 | 20,000 | |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Grant | A | 0.00 | 3,500 | 0 | 78,184 | 74.7 K to 78.2 K (+4.69 %) |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | SVP and Chief Medic ... | Option Exercise | A | 18.69 | 50,000 | 934,500 | 50,000 | |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | SVP and Chief Medic ... | Grant | A | 0.00 | 7,000 | 0 | 34,792 | 27.8 K to 34.8 K (+25.19 %) |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | SVP and Chief Medic ... | Payment of Exercise | F | 31.24 | 940 | 29,366 | 27,792 | 28.7 K to 27.8 K (-3.27 %) |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 18.69 | 45,000 | 841,050 | 45,000 | |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 7,000 | 0 | 78,987 | 72 K to 79 K (+9.72 %) |
| Feb 07 2018 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Executive Chairman | Payment of Exercise | F | 18.42 | 3,137 | 57,784 | 376,237 | 379.4 K to 376.2 K (-0.83 %) |
| Feb 07 2018 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Payment of Exercise | F | 18.42 | 1,048 | 19,304 | 13,314 | 14.4 K to 13.3 K (-7.30 %) |
| Feb 07 2018 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | SVP and Chief Medic ... | Payment of Exercise | F | 18.42 | 1,048 | 19,304 | 23,732 | 24.8 K to 23.7 K (-4.23 %) |
| Feb 07 2018 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Payment of Exercise | F | 18.42 | 930 | 17,131 | 74,684 | 75.6 K to 74.7 K (-1.23 %) |
| Feb 02 2018 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Payment of Exercise | F | 19.73 | 18,866 | 372,226 | 75,614 | 94.5 K to 75.6 K (-19.97 %) |
| Nov 30 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Option Exercise | M | 5.54 | 6,175 | 34,210 | 11,357 | |
| Nov 30 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Buy | M | 5.54 | 6,175 | 34,210 | 177,521 | 171.3 K to 177.5 K (+3.60 %) |
| Nov 02 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | M | 11.65 | 600 | 6,990 | 16,600 | |
| Nov 02 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 45.33 | 600 | 27,198 | 0 | 600 to 0 (-100.00 %) |
| Nov 02 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 600 | 6,990 | 600 | 0 to 600 |
| Oct 24 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Option Exercise | A | 46.80 | 138,450 | 6,479,460 | 138,450 | |
| Oct 16 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Option Exercise | M | 7.26 | 9,655 | 70,095 | 14,735 | |
| Oct 16 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Option Exercise | M | 8.49 | 1,396 | 11,852 | 4,186 | |
| Oct 16 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Buy | M | 7.26 | 9,655 | 70,095 | 171,346 | 161.7 K to 171.3 K (+5.97 %) |
| Oct 16 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Buy | M | 8.49 | 1,396 | 11,852 | 161,691 | 160.3 K to 161.7 K (+0.87 %) |
| Oct 03 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | M | 11.65 | 600 | 6,990 | 17,200 | |
| Oct 03 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | M | 11.65 | 1,200 | 13,980 | 17,800 | |
| Oct 03 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 40.78 | 600 | 24,468 | 0 | 600 to 0 (-100.00 %) |
| Oct 03 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 600 | 6,990 | 600 | 0 to 600 |
| Oct 03 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 40.00 | 1,200 | 48,000 | 0 | 1.2 K to 0 (-100.00 %) |
| Oct 03 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 1,200 | 13,980 | 1,200 | 0 to 1.2 K |
| Oct 02 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | M | 11.65 | 2,000 | 23,300 | 19,000 | |
| Oct 02 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 38.00 | 2,000 | 76,000 | 0 | 2 K to 0 (-100.00 %) |
| Oct 02 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 2,000 | 23,300 | 2,000 | 0 to 2 K |
| Sep 07 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 34.34 | 3,131 | 107,519 | 71,987 | 75.1 K to 72 K (-4.17 %) |
| Sep 06 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Payment of Exercise | F | 34.34 | 7,827 | 268,779 | 381,958 | 389.8 K to 382 K (-2.01 %) |
| Sep 06 2017 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Payment of Exercise | F | 34.34 | 921 | 31,627 | 16,982 | 17.9 K to 17 K (-5.14 %) |
| Sep 06 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Payment of Exercise | F | 34.34 | 3,684 | 126,509 | 160,295 | 164 K to 160.3 K (-2.25 %) |
| Sep 06 2017 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Payment of Exercise | F | 34.34 | 940 | 32,280 | 94,480 | 95.4 K to 94.5 K (-0.99 %) |
| Sep 06 2017 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | SVP and Chief Medic ... | Payment of Exercise | F | 34.34 | 376 | 12,912 | 24,780 | 25.2 K to 24.8 K (-1.49 %) |
| Sep 05 2017 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | SVP, Research | Option Exercise | A | 0.00 | 80,000 | 0 | 80,000 | |
| Sep 05 2017 | FPRX | FIVE PRIME THERAPE ... | Irving Bryan | SVP, Research | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Jun 19 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Option Exercise | M | 5.54 | 8,280 | 45,871 | 17,532 | |
| Jun 19 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Buy | M | 5.54 | 8,280 | 45,871 | 163,548 | 155.3 K to 163.5 K (+5.33 %) |
| May 12 2017 | FPRX | FIVE PRIME THERAPE ... | Gujrathi Sheila | Director | Option Exercise | A | 29.80 | 10,000 | 298,000 | 10,000 | |
| May 12 2017 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | A | 29.80 | 10,000 | 298,000 | 10,000 | |
| May 12 2017 | FPRX | FIVE PRIME THERAPE ... | MCDADE MARK | Director | Option Exercise | A | 29.80 | 10,000 | 298,000 | 10,000 | |
| May 12 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | A | 29.80 | 10,000 | 298,000 | 10,000 | |
| May 12 2017 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | A | 29.80 | 10,000 | 298,000 | 10,000 | |
| May 12 2017 | FPRX | FIVE PRIME THERAPE ... | Nicholson Garry A | Director | Option Exercise | A | 29.80 | 15,000 | 447,000 | 15,000 | |
| May 12 2017 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | A | 29.80 | 10,000 | 298,000 | 10,000 | |
| Apr 26 2017 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | SVP and Chief Medic ... | Grant | A | 0.00 | 1,250 | 0 | 25,156 | 23.9 K to 25.2 K (+5.23 %) |
| Mar 22 2017 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | SVP and Chief Medic ... | Option Exercise | A | 39.21 | 22,500 | 882,225 | 91,500 | |
| Mar 22 2017 | FPRX | FIVE PRIME THERAPE ... | Collins Helen Louise | SVP and Chief Medic ... | Grant | A | 0.00 | 3,750 | 0 | 23,906 | 20.2 K to 23.9 K (+18.60 %) |
| Mar 03 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Payment of Exercise | F | 44.77 | 34,532 | 1,545,998 | 388,754 | 423.3 K to 388.8 K (-8.16 %) |
| Mar 03 2017 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Payment of Exercise | F | 44.77 | 18,899 | 846,108 | 104,158 | 123.1 K to 104.2 K (-15.36 %) |
| Mar 03 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 44.77 | 19,784 | 885,730 | 75,118 | 94.9 K to 75.1 K (-20.85 %) |
| Mar 03 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Payment of Exercise | F | 44.77 | 19,529 | 874,313 | 170,352 | 189.9 K to 170.4 K (-10.28 %) |
| Mar 03 2017 | FPRX | FIVE PRIME THERAPE ... | Borges Luis | SVP, Research | Payment of Exercise | F | 44.77 | 18,084 | 809,621 | 64,888 | 83 K to 64.9 K (-21.80 %) |
| Mar 03 2017 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Payment of Exercise | F | 44.77 | 18,881 | 845,302 | 46,785 | 65.7 K to 46.8 K (-28.75 %) |
| Mar 01 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | M | 11.65 | 500 | 5,825 | 21,000 | |
| Mar 01 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 46.73 | 500 | 23,365 | 0 | 500 to 0 (-100.00 %) |
| Mar 01 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 500 | 5,825 | 500 | 0 to 500 |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | A | 45.38 | 101,250 | 4,594,725 | 101,250 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Grant | A | 0.00 | 16,875 | 0 | 423,286 | 406.4 K to 423.3 K (+4.15 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Gift | G | 0.00 | 22,416 | 0 | 406,411 | 428.8 K to 406.4 K (-5.23 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Option Exercise | A | 45.38 | 30,000 | 1,361,400 | 30,000 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Grant | A | 0.00 | 14,531 | 0 | 123,057 | 108.5 K to 123.1 K (+13.39 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Grant | A | 0.00 | 5,625 | 0 | 108,526 | 102.9 K to 108.5 K (+5.47 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 45.38 | 45,000 | 2,042,100 | 45,000 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 5,768 | 0 | 94,902 | 89.1 K to 94.9 K (+6.47 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 10,310 | 0 | 89,134 | 78.8 K to 89.1 K (+13.08 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Option Exercise | A | 45.38 | 36,920 | 1,675,430 | 36,920 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Grant | A | 0.00 | 5,323 | 0 | 189,881 | 184.6 K to 189.9 K (+2.88 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Grant | A | 0.00 | 9,516 | 0 | 184,557 | 175 K to 184.6 K (+5.44 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Borges Luis | SVP, Research | Option Exercise | A | 45.38 | 25,000 | 1,134,500 | 25,000 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Borges Luis | SVP, Research | Grant | A | 0.00 | 7,031 | 0 | 82,972 | 75.9 K to 83 K (+9.26 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Borges Luis | SVP, Research | Grant | A | 0.00 | 5,625 | 0 | 75,941 | 70.3 K to 75.9 K (+8.00 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | A | 45.38 | 22,500 | 1,021,050 | 22,500 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Grant | A | 0.00 | 7,031 | 0 | 12,656 | 5.6 K to 12.7 K (+125.00 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Grant | A | 0.00 | 5,625 | 0 | 5,625 | 0 to 5.6 K |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Option Exercise | A | 45.38 | 25,000 | 1,134,500 | 25,000 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Grant | A | 0.00 | 7,031 | 0 | 95,420 | 88.4 K to 95.4 K (+7.95 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Grant | A | 0.00 | 5,625 | 0 | 88,389 | 82.8 K to 88.4 K (+6.80 %) |
| Feb 01 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | M | 11.65 | 500 | 5,825 | 21,500 | |
| Feb 01 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 46.17 | 500 | 23,085 | 0 | 500 to 0 (-100.00 %) |
| Feb 01 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 500 | 5,825 | 500 | 0 to 500 |
| Jan 18 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | M | 5.54 | 3,636 | 20,143 | 9,142 | |
| Jan 18 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | S | 47.39 | 3,636 | 172,310 | 78,824 | 82.5 K to 78.8 K (-4.41 %) |
| Jan 18 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Buy | M | 5.54 | 3,636 | 20,143 | 82,460 | 78.8 K to 82.5 K (+4.61 %) |
| Jan 05 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Payment of Exercise | F | 48.60 | 5,065 | 246,159 | 428,827 | 433.9 K to 428.8 K (-1.17 %) |
| Jan 05 2017 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Payment of Exercise | F | 48.60 | 2,115 | 102,789 | 102,901 | 105 K to 102.9 K (-2.01 %) |
| Jan 05 2017 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Payment of Exercise | F | 48.60 | 2,442 | 118,681 | 78,824 | 81.3 K to 78.8 K (-3.00 %) |
| Jan 05 2017 | FPRX | FIVE PRIME THERAPE ... | Borges Luis | SVP, Research | Payment of Exercise | F | 48.60 | 1,306 | 63,472 | 70,316 | 71.6 K to 70.3 K (-1.82 %) |
| Jan 05 2017 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Payment of Exercise | F | 48.60 | 2,281 | 110,857 | 65,666 | 67.9 K to 65.7 K (-3.36 %) |
| Jan 05 2017 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Payment of Exercise | F | 48.60 | 2,957 | 143,710 | 175,811 | 178.8 K to 175.8 K (-1.65 %) |
| Jan 03 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | M | 11.65 | 500 | 5,825 | 22,000 | |
| Jan 03 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 51.07 | 500 | 25,535 | 0 | 500 to 0 (-100.00 %) |
| Jan 03 2017 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 500 | 5,825 | 500 | 0 to 500 |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 5.54 | 29,816 | 165,181 | 31,159 | |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 10 | 85 | 16,349 | |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 6.89 | 19 | 131 | 14,438 | |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 4.56 | 155 | 707 | 91,217 | |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 51.02 | 300 | 15,306 | 433,892 | 434.2 K to 433.9 K (-0.07 %) |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 50.49 | 29,700 | 1,499,553 | 434,192 | 463.9 K to 434.2 K (-6.40 %) |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 5.54 | 29,816 | 165,181 | 463,892 | 434.1 K to 463.9 K (+6.87 %) |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 10 | 85 | 434,076 | 434.1 K to 434.1 K (0.00 %) |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 6.89 | 19 | 131 | 434,066 | 434 K to 434.1 K (0.00 %) |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 4.56 | 155 | 707 | 434,047 | 433.9 K to 434 K (+0.04 %) |
| Dec 02 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | M | 11.65 | 500 | 5,825 | 22,500 | |
| Dec 02 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 57.72 | 500 | 28,860 | 0 | 500 to 0 (-100.00 %) |
| Dec 02 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 500 | 5,825 | 500 | 0 to 500 |
| Nov 30 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | M | 5.54 | 1,710 | 9,473 | 12,778 | |
| Nov 30 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | S | 60.14 | 1,710 | 102,839 | 81,266 | 83 K to 81.3 K (-2.06 %) |
| Nov 30 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Buy | M | 5.54 | 1,710 | 9,473 | 82,976 | 81.3 K to 83 K (+2.10 %) |
| Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | M | 5.54 | 10,264 | 56,863 | 14,488 | |
| Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | M | 6.89 | 10,925 | 75,273 | 0 | |
| Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | M | 6.89 | 13,465 | 92,774 | 10,925 | |
| Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | S | 60.48 | 21,189 | 1,281,511 | 81,266 | 102.5 K to 81.3 K (-20.68 %) |
| Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Buy | M | 5.54 | 10,264 | 56,863 | 102,455 | 92.2 K to 102.5 K (+11.13 %) |
| Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Buy | M | 6.89 | 10,925 | 75,273 | 92,191 | 81.3 K to 92.2 K (+13.44 %) |
| Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Sell | S | 60.23 | 13,465 | 810,997 | 81,266 | 94.7 K to 81.3 K (-14.21 %) |
| Nov 28 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Buy | M | 6.89 | 13,465 | 92,774 | 94,731 | 81.3 K to 94.7 K (+16.57 %) |
| Nov 10 2016 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | M | 7.26 | 4,065 | 29,512 | 0 | |
| Nov 10 2016 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | M | 5.54 | 4,065 | 22,520 | 0 | |
| Nov 10 2016 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Sell | S | 55.30 | 8,130 | 449,589 | 0 | 8.1 K to 0 (-100.00 %) |
| Nov 10 2016 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Buy | M | 7.26 | 4,065 | 29,512 | 8,130 | 4.1 K to 8.1 K (+100.00 %) |
| Nov 10 2016 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Buy | M | 5.54 | 4,065 | 22,520 | 4,065 | 0 to 4.1 K |
| Nov 02 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | M | 11.65 | 500 | 5,825 | 23,000 | |
| Nov 02 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 48.67 | 500 | 24,335 | 0 | 500 to 0 (-100.00 %) |
| Nov 02 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 500 | 5,825 | 500 | 0 to 500 |
| Oct 13 2016 | FPRX | FIVE PRIME THERAPE ... | Douglas R Lee | Director | Option Exercise | M | 1.23 | 2,439 | 3,000 | 0 | |
| Oct 13 2016 | FPRX | FIVE PRIME THERAPE ... | Douglas R Lee | Director | Buy | M | 1.23 | 1,220 | 1,501 | 1,220 | 0 to 1.2 K |
| Oct 04 2016 | FPRX | FIVE PRIME THERAPE ... | MCDADE MARK | Director | Option Exercise | M | 1.85 | 2,439 | 4,512 | 0 | |
| Oct 04 2016 | FPRX | FIVE PRIME THERAPE ... | MCDADE MARK | Director | Option Exercise | M | 1.23 | 10,162 | 12,499 | 0 | |
| Oct 04 2016 | FPRX | FIVE PRIME THERAPE ... | MCDADE MARK | Director | Buy | M | 1.85 | 2,439 | 4,512 | 12,601 | 10.2 K to 12.6 K (+24.00 %) |
| Oct 04 2016 | FPRX | FIVE PRIME THERAPE ... | MCDADE MARK | Director | Buy | M | 1.23 | 10,162 | 12,499 | 10,162 | 0 to 10.2 K |
| Oct 04 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | M | 11.65 | 500 | 5,825 | 23,500 | |
| Oct 04 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 52.00 | 500 | 26,000 | 0 | 500 to 0 (-100.00 %) |
| Oct 04 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 500 | 5,825 | 500 | 0 to 500 |
| Sep 15 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Gift | G | 0.00 | 407 | 0 | 433,892 | 434.3 K to 433.9 K (-0.09 %) |
| Sep 12 2016 | FPRX | FIVE PRIME THERAPE ... | Borges Luis | SVP, Research | Option Exercise | A | 49.54 | 25,000 | 1,238,500 | 25,000 | |
| Sep 12 2016 | FPRX | FIVE PRIME THERAPE ... | Borges Luis | SVP, Research | Grant | A | 0.00 | 5,000 | 0 | 71,622 | 66.6 K to 71.6 K (+7.51 %) |
| Sep 12 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Option Exercise | A | 49.54 | 35,000 | 1,733,900 | 35,000 | |
| Sep 12 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | Chief Strategy Offi ... | Grant | A | 0.00 | 7,000 | 0 | 81,266 | 74.3 K to 81.3 K (+9.43 %) |
| Sep 12 2016 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Option Exercise | A | 49.54 | 50,000 | 2,477,000 | 50,000 |